Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

ViaDerma Inc (EM) VDRM

ViaDerma, Inc., through its subsidiary, manufactures and sells pharmaceutical related products in the United States. The company’s lead product is Vitastem, a tetracycline and topical delivery technology for antibiotics to pain relief, skincare, and other. It is also developing various products for vitiligo, psoriasis, eczema, and other skin conditions using SkinPass topical delivery system, as well as antifungal, cosmetics, and pain management products. In addition, company develops anti-aging skin care, pain management, hair-loss, and toenail fungus products. It also provides licenses for its technology for pharmaceutical industry in various therapeutic areas. The company was formerly known as Décor Products International, Inc. and changed its name to ViaDerma, Inc. in May 2014. ViaDerma, Inc. was incorporated in 2007 and is headquartered in Las Vegas, Nevada.


EXPM:VDRM - Post by User

<< Previous
Bullboard Posts
User Avatar Image
(0)
•••
  • exxeleroX
Post by exxeleroon Jan 14, 2021 10:50am
344 Views
Post# 32293804

Great action!!

Great action!!Glad to see this stock has some action!! Good luck to all those that held! Let's go for 1.00 !!!!
<< Previous
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities